|

Grace Wong
CSO, ActoKine Therapeutics |
Dr. Grace Wong has worked for Genentech,
Millennium, AstraZeneca and Serono on new drug discovery in a
variety of therapeutic areas. Dr. Wong earned a PhD at The Walter
and Eliza Hall Institute of Medical Research in Australia. Dr. Wong
did a postdoc with Dr. David Goeddel at Genentech and advanced basic
research discoveries to product development. In 1996, Dr. Wong
became the Head of Apoptosis Research at Millennium Pharmaceuticals,
worked at AstraZeneca as Section Head of Molecular Genetics and at
Serono as Head of Functional Genomics. She has been awarded 13
scholarships from Australian and American organizations and received
5 Recognition Awards from Genentech.
Dr. Wong has been invited to give presentations at 153 international
conferences including the Nobel Symposium (Sweden, 1994). She has
published 93 papers and filed 28 patents. Some of her publications
(3 Nature, 1 Science, 3 Cell, 5 PNAS, and 7 J. Immunol) have
received 300-1000 citations.
Dr. Wong has founded Actokine Therapeutics (www.actokine.com) for
new drug advancements for cancer, obesity, CNS and emerging viral
diseases. She also founded Student Vision (www.studentvision.org)
and the Nobel Pauling Symposia (www.pauling.us) to help scientists
of all ages in biotechnology.
|